First-in-class oncology therapeutics to treat female and male cancers utilizing membrane-disrupting peptides to target cancer cells without harming healthy tissue
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Esperance Pharmaceuticals plus 4816 other startups.